Premature adrenarche in Prader-Willi syndrome is associated with accelerated pre-pubertal growth and advanced bone age.
Premature adrenarche in Prader-Willi syndrome is associated with accelerated pre-pubertal growth and advanced bone age.
复制标题
Prader-Willi综合征的过早肾上腺素与加速前的前骨生长和晚期骨时代有关。
DOI:
10.1515/jpem-2022-0468
复制
发表时间:
2023-02-23
期刊:
影响因子:
--
通讯作者:
中科院分区:
文献类型:
--
作者:
Prader–Willi syndrome (PWS) is characterized by obesity, growth hormone deficiency, hypogonadism, and a high prevalence of premature adrenarche despite reported hypothalamic–pituitary–adrenal axis dysfunction. While idiopathic premature adrenarche is associated with accelerated pre-pubertal growth and advanced bone age, the consequences of elevated adrenal androgens on growth and bone maturation in PWS remain unknown. This study therefore sought to describe age-related changes in dehydroepiandrosterone sulfate (DHEAS) and their effects on growth and bone maturation in PWS. This retrospective observational study included 62 children with PWS. Simple and multiple regression models were constructed to relate age and BMI-SDS with DHEAS levels. Height velocity was compared to age and sex-based norms with t-tests and two-way ANOVA. Patterns in bone age Z-score were examined with two-way ANOVA, and the contributions of age, BMI-SDS, and DHEAS to bone age Z-score were analyzed with multiple regression. DHEAS levels rose earlier and were less strongly correlated with age in males and females with PWS (R2=0.12 and 0.30) compared to healthy controls (R2=0.89 and 0.88) in a pattern unrelated to BMI-SDS (adjusted R2=0.076, p=0.10 for age, and 0.29 for BMI-SDS). Mid-childhood height velocity was increased in males and preserved in females with PWS before declining at the age of expected puberty (p<0.0001). Peri-adrenarchal bone age was advanced in a manner associated with DHEAS but not BMI-SDS (p<0.0001; adjusted R2=0.48, p=0.0014 for DHEAS, and 0.78 for BMI-SDS). An obesity-independent increase in adrenal androgens is associated with accelerated mid-childhood growth and bone maturation in PWS.
登录
查看更多内容
DOI:
10.1056/nejmoa1302160
发表时间:
2013-06-27
期刊:
The New England journal of medicine
影响因子:
--
作者:
Abreu AP;Dauber A;Macedo DB;Noel SD;Brito VN;Gill JC;Cukier P;Thompson IR;Navarro VM;Gagliardi PC;Rodrigues T;Kochi C;Longui CA;Beckers D;de Zegher F;Montenegro LR;Mendonca BB;Carroll RS;Hirschhorn JN;Latronico AC;Kaiser UB
通讯作者:
Kaiser UB
DOI:
10.1210/jc.2012-3888
发表时间:
2013-06
期刊:
The Journal of clinical endocrinology and metabolism
影响因子:
--
作者:
Deal CL;Tony M;Höybye C;Allen DB;Tauber M;Christiansen JS;2011 Growth Hormone in Prader-Willi Syndrome Clinical Care Guidelines Workshop Participants
通讯作者:
2011 Growth Hormone in Prader-Willi Syndrome Clinical Care Guidelines Workshop Participants
影响因子:
5.8
作者:
Bakker, N. E.;Kuppens, R. J.;Hokken-Koelega, A. C. S.
通讯作者:
Hokken-Koelega, A. C. S.
影响因子:
8
作者:
Butler, Merlin G.;Lee, Jaehoon;Driscoll, Daniel J.
通讯作者:
Driscoll, Daniel J.
影响因子:
5.8
作者:
IBANEZ, L;VIRDIS, R;VICENSCALVET, E
通讯作者:
VICENSCALVET, E